<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03916198</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01-021</org_study_id>
    <nct_id>NCT03916198</nct_id>
  </id_info>
  <brief_title>Polydeoxyribonucleotide (PDRN) for Cuff Regeneration</brief_title>
  <official_title>Effect of Polydeoxyribonucleotide (PDRN) on Healing and Fatty Degeneration of Rotator Cuff in Human</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chuncheon Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Science and ICT</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chuncheon Sacred Heart Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate the effect of polydeoxyribonucleotide (PDRN) for healing and fatty
      degeneration of rotator cuff. The investigators will enroll 130 patients with rotator cuff
      tear who will undergo arthroscopic rotator cuff repair. 130 patients will be classified into
      two group. One group (PDRN) will be injected at the repaired cuff with 3cc
      polydeoxyribonucleotide just after surgery and be injected with another 3ml
      polydeoxyribonucleotide under ultrasound guidance 2 weeks after the surgery. The other group
      (CONTROL) will be injected with 3ml normal saline in the same manner.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polydeoxyribonucleotide is a tissue regeneration activator. It binds an adenosine receptor
      and stimulate VEGF(vascular endothelial growth factor) synthesis and stimulate collagen
      synthesis. Nowadays, a lot of arthroscopic rotator cuff repairs are being performed. but the
      failure rate of rotator cuff repair is considerably high. Therefore, this study is to
      evaluate the effect of polydeoxyribonucleotide for healing and fatty degeneration of rotator
      cuff.

      Visual analog scale (VAS) of pain and other functional scores of the two group will be
      checked preoperatively and postoperative 3, 6, 12, 24 months. Growth factors (VEGF,
      fibroblast growth factor(FGF), insulin like growth factor(IGF)) will be checked
      preoperatively and postoperative 1h, 2 days, 2 weeks, 6 weeks, 3, 6 months. Follow up MRI
      will be checked at postoperative 6 months. The parameters will be compared using statistical
      analysis.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>130 participants with rotator cuff tear will be classified into two group. One group (PDRN) will be injected at the repaired cuff with 3cc polydeoxyribonucleotide just after surgery and be injected with another 3cc polydeoxyribonucleotide under ultrasound guidance 2 weeks after the surgery. The other group (CONTROL) will be injected with 3ml normal saline in the same manner.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>130 participants with rotator cuff tear will be randomly assigned to PDRN or CONTROL depending on the injection material. Randomization will be performed with a computerized random-sequence generator by an independent nurse.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>American Shoulder and Elbow score</measure>
    <time_frame>2 years</time_frame>
    <description>functional score of shoulder between 0 to 100(0: bad, 100: good)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Constant score</measure>
    <time_frame>2 years</time_frame>
    <description>functional score of shoulder between 0 to 100(0: bad, 100: good)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Rotator Cuff Tear</condition>
  <arm_group>
    <arm_group_label>PDRN(polydeoxyribonucleotide)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>polydeoxyribonucleotide 3cc at surgery under arthroscopy guidance and 2 weeks after surgery under ultrasound guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL(normal saline)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline 3cc at surgery under arthroscopy guidance and 2 weeks after surgery under ultrasound guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polydeoxyribonucleotides</intervention_name>
    <description>Just after arthroscopic rotator cuff repair, 3cc polydeoxyribonucleotide will be injected, and 2 weeks after the surgery the same amount of the material will be injected.</description>
    <arm_group_label>PDRN(polydeoxyribonucleotide)</arm_group_label>
    <other_name>PDRN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Just after arthroscopic rotator cuff repair, 3cc normal saline will be injected, and 2 weeks after the surgery the same amount of the material will be injected.</description>
    <arm_group_label>CONTROL(normal saline)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  definite rotator cuff tear on preoperative MRI, which needs repair

          -  acceptance of arthroscopic surgery including rotator cuff repair

        Exclusion Criteria:

          -  history of ipsilateral shoulder operation or fracture

          -  concomitant neurological disorder around the
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jung-Taek Hwang, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chuncheon Sacred Heart Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jung-Taek Hwang, MD,PhD</last_name>
    <phone>82 33 240 5198</phone>
    <email>drakehjt@hanmail.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yunil Choi, Bachelor</last_name>
    <phone>82 33 240 5197</phone>
    <email>yuniri@hallym.or.kr</email>
  </overall_contact_backup>
  <reference>
    <citation>Altavilla D, Squadrito F, Polito F, Irrera N, Calò M, Lo Cascio P, Galeano M, La Cava L, Minutoli L, Marini H, Bitto A. Activation of adenosine A2A receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice. Surgery. 2011 Feb;149(2):253-61. doi: 10.1016/j.surg.2010.04.024. Epub 2010 Jun 8.</citation>
    <PMID>20570301</PMID>
  </reference>
  <reference>
    <citation>Galeano M, Bitto A, Altavilla D, Minutoli L, Polito F, Calò M, Lo Cascio P, Stagno d'Alcontres F, Squadrito F. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008 Mar-Apr;16(2):208-17. doi: 10.1111/j.1524-475X.2008.00361.x.</citation>
    <PMID>18318806</PMID>
  </reference>
  <results_reference>
    <citation>Kang SH, Choi MS, Kim HK, Kim WS, Bae TH, Kim MK, Chang SH. Polydeoxyribonucleotide improves tendon healing following achilles tendon injury in rats. J Orthop Res. 2018 Jun;36(6):1767-1776. doi: 10.1002/jor.23796. Epub 2017 Nov 28.</citation>
    <PMID>29094396</PMID>
  </results_reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>April 12, 2019</last_update_submitted>
  <last_update_submitted_qc>April 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chuncheon Sacred Heart Hospital</investigator_affiliation>
    <investigator_full_name>Jung-Taek Hwang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>healing</keyword>
  <keyword>fatty degeneration</keyword>
  <keyword>retear</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is a privacy problem. The investigators should negotiate with our government about that.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 19, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/98/NCT03916198/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

